Abstract: Cherenkov radiation (CR) imaging is a rapidly evolving technology in radiation therapy, offering unique capabilities for dosimetry, quality assurance (QA), and in-vivo monitoring across conventional and ultra-high dose rate (UHDR) modalities. This presentation will explore CR's applications in beam profiling, tomographic dose reconstruction, small field dosimetry, chemical sensing like tissue oximetry and its clinical translation to human imaging, including applications in conventional and UHDR FLASH radiation therapy. Beyond technology, we will introduce medical physics as a career path, outlining graduate program structure, accreditation, and explore the exciting potential for establishing a medical physics graduate program at the University of Missouri (Mizzou). This presentation highlights the intersection of imaging innovation, programmatic opportunities, and future program development in medical physics.

Bio: Dr. Rongxiao Zhang is an Associate Professor and the Director of Medical Physics in the Department of Radiation Oncology at the University of Missouri School of Medicine. His research interests at Mizzou focus on conventional and FLASH radiation therapy (FLASH-RT) utilizing advanced imaging and dosimetry techniques. Driven by innovation and clinical excellence, his work also includes the co-establishment of medical physics graduate and residency programs at the University of Missouri. Dr. Zhang has comprehensive expertise in radiation therapy, including proton therapy and MR-guided radiation therapy. He was part of the team that captured the first veterinary and human images of Cherenkov radiation, paving the way for advancements in real-time radiation dosimetry and chemical sensing. His broader research interests include molecular imaging, treatment planning technologies, and AI-driven informatics. Dr. Zhang is dedicated to translational research, bridging technological innovation with impactful patient care.